ArticleJACC. Case reports2026
Silent Migration of Retained Epicardial Pacing Wire to the Left Heart 24 Years After CABG.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- When the Wire Doesn't Come Out: Lessons From a 24-Year Silent Migration.JACC. Case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRetained temporary epicardial pacing wires (TEPWs) can migrate after coronary artery bypass grafting; left heart migration is exceedingly rare. CASE SUMMARY: An 81-year-old man presented 24 years after coronary artery bypass grafting. Routine echocardiography revealed a linear echogenic metallic structure traversing the right atrium, atrial septum, left atrium, and mitral valve into the left ventricle, confirmed by transesophageal echocardiography and computed tomography. He was asymptomatic with no infection or thromboembolism, and retrieval was deemed too high risk; thus, he was managed conservatively with anticoagulation (switched to dual antiplatelet therapy given intolerance) and surveillance every 6 months, remaining clinically stable at 1 year. DISCUSSION: Left-sided TEPW migration poses unique thromboembolic risks. Unlike prior cases, ours lacked infection, followed a novel transatrial trajectory, and represented the longest reported asymptomatic interval (24 years), underscoring conservative management in carefully selected patients. TAKE-HOME MESSAGES: Left-sided TEPW migration can remain asymptomatic for decades. Conservative management with anticoagulation and serial surveillance is viable in the absence of infection, hemodynamic compromise, or further migration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.